Clinical Trials Directory

Trials / Terminated

TerminatedNCT01434953

Prehypertension Labeling

Diagnostic Labeling: Effect on White Coat Hypertension

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Columbia University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to find out whether labeling adults with prehypertension has negative effects on clinic blood pressure and quality of life 3 months after diagnosis.

Detailed description

Previous research has shown that a diagnosis of hypertension is associated with subsequent increases in resting blood pressure, and there is preliminary evidence of a cross-sectional association between hypertension labeling and the white coat effect. The white coat effect may be particularly problematic in prehypertensives, because a small elevation in clinic blood pressure could result in crossing the diagnostic cutoff for hypertension, potentially leading to misdiagnosis and unnecessary treatment. This study will examine effects of prehypertension labeling on clinic and ambulatory blood pressure, and will examine potential psychological mediators of these associations.

Conditions

Interventions

TypeNameDescription
BEHAVIORALLabeled prehypertensionA study physician informs subjects of their blood pressure level. Subjects are told they have prehypertension and are informed of the associated health risks.
BEHAVIORALUnlabeled prehypertensionA study physician informs subjects of their blood pressure level. The term "prehypertension" is not used and associated health risks are not discussed.

Timeline

Start date
2009-07-13
Primary completion
2012-07-09
Completion
2012-07-09
First posted
2011-09-15
Last updated
2017-07-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01434953. Inclusion in this directory is not an endorsement.